{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,25]],"date-time":"2026-01-25T01:26:16Z","timestamp":1769304376309,"version":"3.49.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T00:00:00Z","timestamp":1757203200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","award":["101016167"],"award-info":[{"award-number":["101016167"]}],"id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ijidonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.ijid.2025.108053","type":"journal-article","created":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T16:32:51Z","timestamp":1757349171000},"page":"108053","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Risk factors for persisting SARS-CoV-2 infection in patients with B-cell malignancies in the Omicron era: A multicenter cohort study"],"prefix":"10.1016","volume":"160","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5581-9887","authenticated-orcid":false,"given":"Zeno","family":"Pasquini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alice","family":"Toschi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dino","family":"Gibertoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Armando","family":"Amicucci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beatrice","family":"Casadei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cinzia","family":"Pellegrini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandra","family":"D\u2019Abramo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrizia","family":"De Marco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linda","family":"Bussini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Ciccone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro","family":"Visentin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paula","family":"Olivares-Navarro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michele","family":"Bartoletti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emanuele","family":"Nicastri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mauro","family":"Krampera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pier Luigi","family":"Zinzani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Bonifazi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierluigi","family":"Viale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zaira R.","family":"Palacios-Baena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evelina","family":"Tacconelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maddalena","family":"Giannella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijid.2025.108053_bib0001","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/S1470-2045(22)00273-X","article-title":"Outcomes of the SARS-CoV-2 omicron (B.1.1.529) variant outbreak among vaccinated and unvaccinated patients with cancer in Europe: results from the retrospective, multicentre, OnCovid registry study","volume":"23","author":"Pinato","year":"2022","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijid.2025.108053_bib0002","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1001\/jamainternmed.2021.7024","article-title":"Association between immune dysfunction and COVID-19 breakthrough infection after SARS-CoV-2 vaccination in the US","volume":"182","author":"Sun","year":"2022","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.ijid.2025.108053_bib0003","article-title":"Impact of COVID-19 on immunocompromised populations during the Omicron era: insights from the observational population-based INFORM study","volume":"35","author":"Evans","year":"2023","journal-title":"Lancet Reg Health Eur"},{"key":"10.1016\/j.ijid.2025.108053_bib0004","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1016\/j.immuni.2022.09.006","article-title":"SARS-CoV-2 in immunocompromised individuals","volume":"55","author":"DeWolf","year":"2022","journal-title":"Immunity"},{"key":"10.1016\/j.ijid.2025.108053_bib0005","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/s41586-021-03291-y","article-title":"SARS-CoV-2 evolution during treatment of chronic infection","volume":"592","author":"Kemp","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.ijid.2025.108053_bib0006","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1093\/cid\/ciaa451","article-title":"Duration of viral shedding of discharged patients with severe COVID-19","volume":"71","author":"Zhou","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2025.108053_bib0007","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1158\/2159-8290.CD-21-1033","article-title":"Prolonged SARS-CoV-2 infection in patients with lymphoid malignancies","volume":"12","author":"Lee","year":"2022","journal-title":"Cancer Discov"},{"key":"10.1016\/j.ijid.2025.108053_bib0008","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1038\/s41586-024-07029-4","article-title":"Prevalence of persistent SARS-CoV-2 in a large community surveillance study","volume":"626","author":"Ghafari","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.ijid.2025.108053_bib0009","article-title":"COVID-19 Genomics UK (COG-UK) consortium. Persistent SARS-CoV-2 infection in immunocompromised patients facilitates rapid viral evolution: retrospective cohort study and literature review","volume":"16","author":"Hettle","year":"2022","journal-title":"Clin Infect Pract"},{"key":"10.1016\/j.ijid.2025.108053_bib0010","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1007\/s15010-023-02138-0","article-title":"Clinical phenotype and outcome of persistent SARS-CoV-2 replication in immunocompromised hosts: a retrospective observational study in the Omicron era","volume":"52","author":"G\u00f6tz","year":"2024","journal-title":"Infection"},{"key":"10.1016\/j.ijid.2025.108053_bib0011","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s40472-022-00385-y","article-title":"Immunocompromised patients with protracted COVID-19: a review of \u201clong persisters","volume":"9","author":"Dioverti","year":"2022","journal-title":"Curr Transplant Rep"},{"key":"10.1016\/j.ijid.2025.108053_bib0012","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cmi.2022.10.007","article-title":"The unique presentation of SARS-CoV-2 infection in patients with B-cell depletion: definition of 'persistent inflammatory sero-negative COVID","volume":"29","author":"Belkin","year":"2023","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijid.2025.108053_bib0013","series-title":"A clinical case definition of post COVID-19 condition by a Delphi consensus","year":"2021"},{"key":"10.1016\/j.ijid.2025.108053_bib0014","article-title":"Case report: Sotrovimab, remdesivir and nirmatrelvir\/ritonavir combination as salvage treatment option in two immunocompromised patients hospitalized for COVID-19","volume":"9","author":"Baldi","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.ijid.2025.108053_bib0015","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1093\/cid\/ciac868","article-title":"Successful treatment of prolonged, severe COVID-19 lower respiratory tract disease in a B-cell ALL patient with an extended course of remdesivir and nirmatrelvir\/ritonavir","volume":"76","author":"Ford","year":"2023","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2025.108053_bib0016","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1002\/hon.3206","article-title":"Dual combined antiviral treatment with remdesivir and nirmatrelvir\/ritonavir in patients with impaired humoral immunity and persistent SARS-CoV-2 infection","volume":"41","author":"Pasquini","year":"2023","journal-title":"Hematol Oncol"},{"key":"10.1016\/j.ijid.2025.108053_bib0017","series-title":"Clinical management of COVID-19: living guideline","year":"2023"},{"key":"10.1016\/j.ijid.2025.108053_bib0018","doi-asserted-by":"crossref","DOI":"10.1158\/1557-3265.COVID-19-21-S09-02","article-title":"Abstract S09-02: High incidence of persistent COVID-19 among patients with lymphoma treated with B-cell depleting immunotherapy","volume":"27","author":"Lamure","year":"2021","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ijid.2025.108053_bib0019","doi-asserted-by":"crossref","first-page":"e263","DOI":"10.3346\/jkms.2024.39.e263","article-title":"Long-term outcomes of COVID-19 and risk factors for prolonged or persistent COVID-19 in lymphoma patients: a multicenter, retrospective cohort study","volume":"39","author":"Lee","year":"2024","journal-title":"J Korean Med Sci"},{"key":"10.1016\/j.ijid.2025.108053_bib0020","doi-asserted-by":"crossref","first-page":"e603","DOI":"10.1097\/HS9.0000000000000603","article-title":"COVID-19 in patients receiving CD20-depleting immunochemotherapy for B-cell lymphoma","volume":"5","author":"Gaitzsch","year":"2021","journal-title":"Hemasphere"},{"key":"10.1016\/j.ijid.2025.108053_bib0021","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1186\/s12879-024-09631-3","article-title":"The evaluation of risk factors for prolonged viral shedding during anti-SARS-CoV-2 monoclonal antibodies and long-term administration of antivirals in COVID-19 patients with B-cell lymphoma treated by anti-CD20 antibody","volume":"24","author":"Maruyama","year":"2024","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.ijid.2025.108053_bib0022","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1007\/s15010-023-02039-2","article-title":"Persistent SARS-CoV-2 infection with multiple clinical relapses in two patients with follicular lymphoma treated with Bendamustine and obinutuzumab or rituximab","volume":"51","author":"Franceschini","year":"2023","journal-title":"Infection"},{"key":"10.1016\/j.ijid.2025.108053_bib0023","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.jtct.2021.09.016","article-title":"State of the CAR-T: risk of infections with chimeric antigen receptor T-cell therapy and determinants of SARS-CoV-2 vaccine responses","volume":"27","author":"Meir","year":"2021","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.ijid.2025.108053_bib0024","doi-asserted-by":"crossref","first-page":"116.e1","DOI":"10.1016\/j.jtct.2023.09.027","article-title":"Outcomes and management of the SARS-CoV2 Omicron variant in recipients of hematopoietic cell transplantation and chimeric antigen receptor T cell therapy","volume":"30","author":"Infante","year":"2024","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.ijid.2025.108053_bib0025","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.36678","article-title":"Nirmatrelvir-ritonavir and COVID-19 mortality and hospitalization among patients with vulnerability to COVID-19 complications","volume":"6","author":"Dormuth","year":"2023","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.ijid.2025.108053_bib0026","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0140-6736(22)02597-1","article-title":"Molnupiravir plus usual care versus usual care alone as early treatment for adults with COVID-19 at increased risk of adverse outcomes (PANORAMIC): an open-label, platform-adaptive randomised controlled trial","volume":"401","author":"Butler","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.ijid.2025.108053_bib0027","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1002\/ana.26309","article-title":"B cell depletion and SARS-CoV-2 vaccine responses in neuroimmunologic patients","volume":"91","author":"Kornek","year":"2022","journal-title":"Ann Neurol"},{"key":"10.1016\/j.ijid.2025.108053_bib0028","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1186\/s12879-024-10063-2","article-title":"Inactivated vaccine dosage and serum IgG levels correlate with persistent COVID-19 infections in hematologic malignancy patients during the Omicron surge in China","volume":"24","author":"Ye","year":"2024","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.ijid.2025.108053_bib0029","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofad500.2244","article-title":"Duration of viable SARS-CoV-2 shedding in immunocompromised COVID-19 patients during the widespread vaccination era","volume":"10","author":"Kanai","year":"2023","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.ijid.2025.108053_bib0030","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/bjh.19156","article-title":"Low mortality from COVID-19 infection in patients with B-cell lymphoma after bispecific CD20xCD3 therapy","volume":"204","author":"Kyvsgaard","year":"2024","journal-title":"Br J Haematol"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971225002759?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971225002759?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T04:12:21Z","timestamp":1761192741000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971225002759"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":30,"alternative-id":["S1201971225002759"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2025.108053","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk factors for persisting SARS-CoV-2 infection in patients with B-cell malignancies in the Omicron era: A multicenter cohort study","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2025.108053","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}],"article-number":"108053"}}